openPR Logo
Press release

Geriatric Population Pool to Broaden Prospects of Geriatric Medicines with Rampant Adoption in North America | AstraZeneca, Merck & Co, Inc., Pfizer, Inc., Novartis AG, Bristol-Myers Squibb Company

02-04-2021 10:46 PM CET | Health & Medicine

Press release from: Fact.MR

Geriatric Population Pool to Broaden Prospects of Geriatric

The global geriatric medicines market is projected to rise at a healthy 6% CAGR between 2020 and 2026. As per the Fact.MR report, the global geriatrics demographic is especially vulnerable to the effects of the COVID-19 virus. The crisis period has substantially increased the demand for medications such as Metformin, diuretics, NSAIDs, and ACE inhibitors. Such a trend will have a positive impact on the geriatric medicines market in the short term.

"The higher number of adults over 60 years are affected by chronic conditions ailments such as neurological disorders, cancer, rheumatoid arthritis, and cardiovascular disorders which are driving the expansion of the global geriatric medicines market during and after the pandemic," says the FACT.MR report.

Get U.S Region Sample Of The Report >>> https://www.factmr.com/connectus/sample?flag=S&rep_id=4746

Geriatric Medicines Market- Key Takeaways

Analgesics remain highly sought after, propelled by rise in pain management prescriptions.

Cardiovascular disease applications contribute substantially to revenue owing to prevalence of artery disease and hypertension.

Diabetes medications are gaining higher demand share owing to poor lifestyle standards among the elderly.

North America and Asia Pacific are major, fast growing markets, supported by advances in healthcare facilities to launch generic drugs.

Geriatric Medicines Market- Driving Factors

Rapid growth of the global elderly population demographic is the primary factor supporting the adoption of geriatric medicines.

The incidences of specific diseases, coupled with lower immunity levels of the elderly support market growth.

Higher investments in the healthcare sector promotes key market developments.

Request Methodology & Get a Glimpse of Our Expertise >>> https://www.factmr.com/connectus/sample?flag=RM&rep_id=4746

Geriatric Medicines Market- Major Restraints

Poor reimbursement policies for geriatrics are set to hold back adoption of geriatric medicine.

High capital costs of medication development to hinder market growth.

COVID-19 Impact on Geriatric Medicines Market

The coronavirus outbreak has is having a positive impact on the geriatrics medicine market, driven by strong demand for antibiotics, antidiabetics, and others. However, the dependence of global supply chains on China for drugs and intermediate chemicals including APIs will create challenges for market players during the pandemic.

Competitive Landscape

The geriatric medicines market players are leveraging high growth segments and pushing for expansion in untapped markets. For instance, Acacia Pharma has announced FDA approval of BYFAVO drug for procedural sedation. Pfizer, GlaxoSmithKline, Novartis, and AstraZeneca are some of the top geriatric medicine manufacturers in the global market. 

Request Customized Report As Per Your Requirements >>> https://www.factmr.com/connectus/sample?flag=RC&rep_id=4746

About the Report

This study offers readers a comprehensive market forecast of the geriatric medicines market. Global, regional and country-level analysis of the top industry trends impacting the geriatric medicines market is covered in this FACT.MR study. The report offers insights on the geriatric medicines market on the basis of therapeutic category (analgesic, anti-hypertensive, statins, anti-diabetic, proton pump inhibitor, anti-coagulant, anti-psychotic and anti-depressants), condition (cardiovascular, arthritis, diabetes, neurological, cancer, osteoporosis, respiratory, and others), and distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies) across five regions (North America, Latin America, Europe, Asia Pacific, and MEA).

Browse Full Report, visit >>> https://www.factmr.com/media-release/1507/global-geriatric-medicines-market

 

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in the United States and Dublin, Ireland. Reach out to us with your goals, and we’ll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Geriatric Population Pool to Broaden Prospects of Geriatric Medicines with Rampant Adoption in North America | AstraZeneca, Merck & Co, Inc., Pfizer, Inc., Novartis AG, Bristol-Myers Squibb Company here

News-ID: 2236731 • Views:

More Releases from Fact.MR

Tungsten Carbide Market to Reach USD 38.4 Billion by 2035, Driven by Metalworking and Aerospace Investments, Reports Fact.MR
Tungsten Carbide Market to Reach USD 38.4 Billion by 2035, Driven by Metalworkin …
The global tungsten carbide market is projected to reach USD 38.4 billion by 2035, rising from USD 22.8 billion in 2025, according to the latest report by Fact.MR. The market is anticipated to expand at a compound annual growth rate (CAGR) of 5.3%, underpinned by accelerating industrial automation, increased demand from metal cutting and mining sectors, and surging applications in the aerospace and defense industries. The Fact.MR study, "Tungsten Carbide Market
Airless Tires Market to Surpass USD 3.8 Billion by 2035; EV Expansion and Defense Applications Accelerate Adoption, Reports Fact.MR
Airless Tires Market to Surpass USD 3.8 Billion by 2035; EV Expansion and Defens …
The global airless tires market is set to reach USD 3.8 billion by 2035, growing from USD 1.5 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%, according to the latest analysis by Fact.MR. The surge is powered by the rapid electrification of vehicles, expansion of defense-grade tire applications, and the global shift toward maintenance-free sustainable mobility systems. The Fact.MR study, "Airless Tires Market Size, Share, and Forecast
Fine Blanking Tools Market Projected to Reach USD 1.43 Billion by 2035 | U.S. CAGR at a 5.3%
Fine Blanking Tools Market Projected to Reach USD 1.43 Billion by 2035 | U.S. CA …
The global Fine Blanking Tools Market is set for steady growth over the next decade, driven by rising demand for high-precision components, ongoing industrial automation, and surging requirements from automotive, electronics, and aerospace sectors. According to a recent forecast, the market is expected to grow from approximately USD 948.1 million in 2025 to USD 1,430.6 million by 2035, at a compound annual growth rate (CAGR) of about 4.2 % between
Benzodiazepine Drugs Market is Expanding USD 5.4 billion by 2035 | Pfizer Inc.; Akorn Inc; Hikma; Hameln Pharmaceutical; Accord; Others.
10-08-2025 | Health & Medicine
Fact.MR
Benzodiazepine Drugs Market is Expanding USD 5.4 billion by 2035 | Pfizer Inc.; …
The global benzodiazepine drugs market is projected to expand in the coming decade, driven by growing incidence of anxiety, insomnia, alcohol-withdrawal disorders, and advances in pharmaceutical formulations. According to a recent Fact.MR report, the market was valued at approximately USD 2.35 billion in 2022, and is expected to grow at a compound annual growth rate (CAGR) of 2.8% to reach USD 3.1 billion by 2032. Market Drivers & Outlook The demand for

All 5 Releases


More Releases for Geriatric

Geriatric Care Services Market Report 2024 - Geriatric Care Services Market Size …
"The Business Research Company recently released a comprehensive report on the Global Geriatric Care Services Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The geriatric care services
Rising Geriatric Population Proliferates Precision Cardiology Industry
The precision cardiology market generates $1,011.5 million in revenue in 2021, and it is projected to grow at a rate of 12.8% from 2021 to 2030, to capture $2,998.4 million in revenue in 2030. It is ascribed to the declining cost of the sequencing methods, and rising awareness of early screening of cardiovascular diseases due to their increasing prevalence. Market Overview@ https://www.psmarketresearch.com/market-analysis/precision-cardiology-market In addition, the industry is progressing with technological advancements in
Geriatric Care Devices Market 2021 | Detailed Report
According to Market Study Report, Geriatric Care Devices Market provides a comprehensive analysis of the Geriatric Care Devices Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC, Tables and Figures) of Geriatric Care Devices Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5042670 The report provides a
Soaring Geriatric Demographic & Sophisticated Technology Buttress Geriatric Medi …
Governments’ relentless pitch for all-round assistance for geriatric people along with technological advancements aimed at ameliorating medical assistance has underpinned the geriatric medicines market. One of the insurance programs in the United States named as the Federal Long Term Care Insurance Program has aptly incorporated near-to-full medical cost of the Americans. Factors such as longer life-expectancy, aging demographic, swelled awareness and adoption of sophisticated therapeutics are prophesized to propel the
Consistent Rise in Geriatric Population is Expected to Stimulate the Growth of G …
Geriatric population is more susceptible to chronic diseases such as heart problems, joint disorders and others. Therefore, this population group needs regular use of the medicines to prevent the disease conditions. The use of complementary and alternative medicines is increasing among the geriatric population globally due to the fact that CAMs decreases the risk of adverse reactions and drug interactions. Complementary and alternative medicines include products such as dietary medicine
Consistent Rise in Geriatric Population is Expected to Stimulate Geriatric Compl …
Geriatric Complementary and Alternative Medicines (CAM) Market: Overview Geriatric population is more susceptible to chronic diseases such as heart problems, joint disorders and others. Therefore, this population group needs regular use of the medicines to prevent the disease conditions. The use of complementary and alternative medicines is increasing among the geriatric population globally due to the fact that CAMs decreases the risk of adverse reactions and drug interactions. Browse to unlock